Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin

Martínez Ruiz, Laura; López Rodríguez, Alba; Florido Ruiz, Javier; Rodríguez Santana, César; Rodríguez Ferrer, José Manuel; Acuña Castroviejo, Darío; Escames Rosa, Germaine

doi:10.1016/j.biopha.2023.115581

1-s2.0-S0753332223013793-main.pdf (2.230Mb)

Identificadores

URI: https://hdl.handle.net/10481/85543

DOI: 10.1016/j.biopha.2023.115581

Exportar

Editorial

Elsevier

Materia

Melatonin

Patient-derived models

Cancer therapies

PDX

Date

2023-09-23

Referencia bibliográfica

L. Martinez-Ruiz et al. Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin. Biomedicine & Pharmacotherapy 167 (2023) 115581 [https://doi.org/10.1016/j.biopha.2023.115581]

Sponsorship

MCIN/AEI/10.13039/ 501100011033/; The European Regional Development Fund (B-CTS-071-UGR18); University of Granada (Grant “UNETE,” UCEPP2017- 05), Spain; Unión Europea “NextGenerationEU”/ PRTR (PID2020-115112RB- I00; SAF2017-85903-P); Consejería de Economía , Innovación, Ciencia y Empleo, Junta de Andalucía (P18- RT-32222); Ministerio de Educación Cultura y Deporte, Spain

Collections

OpenAIRE (Open Access Infrastructure for Research in Europe)

Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional